Kidney Transplant Medication - enteric-coated myfortic mycophenolic acid delayed-release tablet





Healthcare Professionals



Renal Transplant Patient Handout

Important myfortic Trials




Important Safety Information
  Novartis Pharma US

 
myfortic: It's All in the Delivery


myfortic®: It's All in the Delivery


This section presents the data from clinical studies showing the therapeutic equivalency of myfortic, an enteric-coated formulation of mycophenolic acid, compared to CellCept®. Also included is a complete bibliography for these data.



The myfortic Option  >>
myfortic: Comparable Efficacy  >>
Efficacy for De Novo Patients >>
myfortic: Safety Profile >>
myfortic: Dosing >>
myfortic: References >>

Click here for full prescribing information, which includes contraindications, warnings, precautions, and adverse events.




CellCept® is a registered trademark of Roche Laboratories, Inc.

myfortic Home | Healthcare Professionals Home | myfortic: It's All in the Delivery Renal Transplant Resources | Renal Transplant Patient Handout Important myfortic Trials | Reimbursement Information Prescribing Information | Important Safety Information Site Guide | Site Map | Contact Us
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.